By the end of 2015, more than $26 billion had so far been recovered by the Government under the federal False Claims Act, and this year the trend for ever increasing levels of Qui Tam investigations and enforcement shows no sign of letting up. With big pharma reaching several record-breaking settlements for FCA claims in the first nine months of 2016, and with several landmark court decisions, most notably the SCOTUS ruling in the Escobar case on implied false certification and materiality, it has never been more crucial for private practitioners and corporate in-house counsel to keep abreast of the changes and hear a wide variety of perspectives on this rapidly evolving and highly challenging area of the law.

Now in its fourth highly successful year, American Conference Institute’s Advanced Forum on False Claims and Qui Tam Enforcement returns to New York City with a new venue at the Park Lane Hotel in Manhattan. This must-attend event provides the most up-to-date guidance and analysis available right from the most respected practitioners in the field, whether Government Prosecutors, Defense or Relator Bar, or leading In-House Counsel across the affected industries on the rapidly changing landscape of FCA enforcement. Take advantage of the opportunity to meet leading industry decisionmakers from organizations such as:

• Johnson & Johnson
• Sanofi
• The Boeing Company
• Medtronic
• Lockheed Martin
• Vertex Pharmaceuticals
• Anthem Inc.
• Merck Sharp & Dohme Corp

This bespoke two-day forum has been specifically designed for in-house counsel and chief compliance officers in the healthcare, pharmaceutical, defense, aerospace and financial services industries; as well for private practitioners in this field, to stimulate discussion and analysis in this rapidly evolving and highly active area of the law. You will hear directly from the leading practitioners in the field who have actually defended and settled these cases, as well as the view from top US attorneys and Relator Bar who prosecute them. All this in addition to having a chance to network and engage with a wide range of practitioners and in-house executives from across the country.

Join Reed Smith Partner Larry Sher for his presentation entitled "In Depth Look at Damages and Liability."  Topics include:

• How the Government and Qui Tam plaintiffs are increasingly using statistical sampling and extrapolation to establish liability and damages in FCA cases
• Analysis of United States ex. rel. Michaels v Agape Senior Community; United States ex. rel. Paradies et al. v AseraCare; United States ex rel. Wall v. Vista Hospice Care; and other cases in 2016 which pave the way for clearer guidance on use of statistical sampling
• Strategies for challenging the Government’s (or Qui Tam plaintiffs’) use of statistical sampling in FCA Cases
• Rejection of Government’s damages measure in United States ex. rel. Wall v Circle C Construction: will this limit prosecutors’ power to equate damages to actual loss?